Abstract
Abstract
Background:
SARS-CoV-2 variant tracking is key to the genomic surveillance of the COVID-19 pandemic. While next-generation sequencing (NGS) is commonly used for variant determination, it is expensive and time-consuming. Variant-specific PCR (vsPCR) is a faster, cheaper method that detects specific mutations that are considered variant-defining. These tests usually rely on specific amplification when a mutation is present or a specific melting temperature peak after amplification.
Case presentation:
A discrepant result between vsPCR and NGS was found in seventeen SARS-CoV-2 samples from Galicia, Spain. A cluster of BA.1 Omicron SARS-CoV-2 variant showed a BA.2-like melting temperature pattern due to a point mutation (C21772T) downstream the deletion of the spike amino acids 69/70. As the 69/70 deletion is widely used for differentiation between BA.1 and BA.2 by vsPCR, C21772T can cause BA.1 samples to be misinterpreted as BA.2. Over a thousand BA.1 sequences in the EpiCoV database contain this mutation.
Conclusions:
To our knowledge, this is the first case of a point mutation causing a vsPCR algorithm to misclassify BA.1 samples as BA.2. This is an example of how mutations in the probe target area of vsPCR tests based on melting curve analysis can lead to variant misclassification. NGS confirmation of vsPCR results is relevant for the accuracy of the epidemiological surveillance. In order to overcome the possible impact of novel mutations, diagnostic tools must be constantly updated.
Funder
European Centre for Disease Prevention and Control
Consellería de Sanidade, Xunta de Galicia, Spain
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Virology
Reference24 articles.
1. Ong DSY, Koeleman JGM, Vaessen N, Breijer S, Paltansing S, de Man P. Rapid screening method for the detection of SARS-CoV–2 variants of concern. J Clin Virol Off Publ Pan Am Soc Clin Virol. 2021 Aug;141:104903.
2. Molenkamp R, Fanoy E, Derickx L, Groot T de, Jonges M, Leenstra T, et al. Supplementing SARS-CoV–2 genomic surveillance with PCR-based variant detection for real-time actionable information, the Netherlands, June to July 2021. Eurosurveillance. 2021 Oct 7;26(40):2100921.
3. Ferré VM, Peiffer-Smadja N, Visseaux B, Descamps D, Ghosn J, Charpentier C. Omicron SARS-CoV–2 variant: What we know and what we don’t. Anaesth Crit Care Pain Med. 2022 Feb;41(1):100998.
4. Covid–19 - TIB MOLBIOL. VirSnip assays [Internet]. [cited 2022 May 19]. Available from: https://www.tib-molbiol.de/covid–19.
5. Hain Fluorotype SARS-CoV–2 varID Q [Internet]. [cited 2022 May 19]. Available from: https://www.hain-lifescience.de/en/products/virology/coronavirus/fluorotype-sars-cov–2-varid-q.html.